Daicel Corporation (TYO:4202)

Market Cap	324.79B
Revenue (ttm)	576.33B
Net Income (ttm)	55.67B
Shares Out	265.13M
EPS (ttm)	202.18
PE Ratio	6.06
Forward PE	5.91
Dividend	60.00 (4.92%)
Ex-Dividend Date	Mar 28, 2025

Volume	1,930,300
Average Volume	641,080
Open	1,255.00
Previous Close	1,225.00
Day's Range	1,206.50 - 1,272.00
52-Week Range	1,059.00 - 1,640.00
Beta	0.20
RSI	51.86
Earnings Date	May 13, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1919
• Employees: 11,134
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4202

Financial Performance

In 2023, Daicel's revenue was 558.06 billion, an increase of 3.72% compared to the previous year's 538.03 billion. Earnings were 55.83 billion, an increase of 37.24%.